Skip to content

WHeezing Illnesses Study Leidsche Rijn / Childhood adiposity and Arterial Disease Onset 2

WHeezing Illnesses Study Leidsche Rijn / Childhood adiposity and Arterial Disease Onset 2 - WHISTLER/Cardio 2

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON43961
Enrollment
1000
Registered
2010-08-25
Start date
2010-10-27
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cardiovasculaire aandoeningen en overgewicht Cardiovascular diseases and overweight

Interventions

None listed

Sponsors

Universitair Medisch Centrum Utrecht
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: children who reached the age of 8 years and who already participated to the WHISTLER and WHISTLER/Cardio study, and who's parents are willing to give informed consent to participate to this study.

Exclusion criteria

Exclusion criteria: There are no exclusion criteria. In case of current or recent (last week) infections, the second visit to obtain the blood sample will be rescheduled. (this is not applicable after may 2012, as the venipuncture has stopped).

Design outcomes

Primary

MeasureTime frame
To study the association between fat distribution and the adipokine profile in childhood, the main study parameters consist of anthropometric parameters, namely weight, quetelet index, waist circumference, and the main outcome parameters are the adipokine concentrations and clusters of adipocytokines. Moreover, to determine the effect of adipocytokines on the vascular system, the adipokine profile is used as determinant and the main outcome parameters are the carotid IMT and vascular stiffness. In the second part of the study the main study parameters are changes in fat distribution between the age of 5 and 8 years. The main outcome parameters are the changes in Z-score IMT and distension at the age of 8 years.

Secondary

MeasureTime frame
Since the abdominal fat will be measured ultrasonographically as well, secondary study parameters will be the intra-abdominal fat and subcutaneous fat as determinants of adipokine concentration and of IMT and vascular stiffness.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)